Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST)

N. Hoyer (Copenhagen, Denmark), L. Thomsen (Copenhagen, Denmark), M. Wille (Copenhagen, Denmark), T. Wilcke (Copenhagen, Denmark), A. Dirksen (Copenhagen, Denmark), J. Pedersen (Copenhagen, Denmark), Z. Saghir (Copenhagen, Denmark), H. Ashraf (Loerenskog, Norway), S. Shaker (Copenhagen, Denmark)

Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Hoyer (Copenhagen, Denmark), L. Thomsen (Copenhagen, Denmark), M. Wille (Copenhagen, Denmark), T. Wilcke (Copenhagen, Denmark), A. Dirksen (Copenhagen, Denmark), J. Pedersen (Copenhagen, Denmark), Z. Saghir (Copenhagen, Denmark), H. Ashraf (Loerenskog, Norway), S. Shaker (Copenhagen, Denmark). Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST). 1939

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung cancer in never smokers. An update of the Lung Cancer Risk Factors in Never Smokers Study (LCRINS)
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Consequences of Lung Cancer: Mortality and Comorbidity in Danish Patients with Lung Cancer 1998-2010
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Causes of Hospitalization and Mortality in Lung Cancer Patients
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018

The Role Of TGF-ß in Lung Cancer Development in COPD Patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020


The Burden of Asymptomatic Lung Cancer
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019

Lung Micobiome in Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020


DANILDA – The First Danish National Interstitial Lung Disease Registry
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

Romanian Registry for Interstitial Lung Diseases (REGIS): inclusion of patients in 3 years
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Associated Factors with the Approval of Pulmonary Rehabilitation for Inpatients with Interstitial Lung Disease: Two-center Retrospective Study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Eligibility for Lung Volume Reduction in patients with COPD attending Pulmonary Rehabilitation
Source: Virtual Congress 2020 – Challenging issues in thoracic surgery
Year: 2020




Contamination during 4-5 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST)
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010


Multicenter Registry of Interstitial Lung Diseases in Brazil
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Association Between Pain Level and Fatigue Level with Activities of Daily Living in Lung Cancer Patients Receiving Inpatient Cancer Therapy: A Pilot Study
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020


Five year Cohort Analysis of Non-Tuberculosis Mycobacterium Lung Disease at a Tertiary Referral Centre
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

Short Term Multidisciplinary Pulmonary Rehabilitation Is Effective In Early Stage Non Small Cell Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Childhood Interstitial Lung disease: A Tertiary Single Center Experience
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


Lung Microbiota and Streptococcal enrichment in Central Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020